Literature DB >> 16352338

Haematological malignancies--a predictor of a poor outcome in patients with bacteraemia.

Mette Nørgaard1, Heidi Larsson, Gitte Pedersen, Henrik Carl Schønheyder, Henrik Toft Sørensen.   

Abstract

OBJECTIVES: To compare microbial agents causing first episodes of bacteraemia in patients with and without haematological malignancies, and to examine mortality within 90 days of follow-up.
METHODS: We conducted a population-based study in North Jutland County, Denmark including patients (> or = 15 years) registered in the County Bacteraemia Registry with their first episode of bacteraemia during the period 1992-2002. Diseases prior to the bacteraemia were identified in the Hospital Discharge Registry. Mortality was determined through the Civil Registration System. We estimated adjusted mortality rate ratios (MRRs) using Cox's regression analysis.
RESULTS: We included 7456 patients with a first episode of bacteraemia; of these, 444 (6%) had a haematological malignancy. Haematological patients had almost the same proportions of gram-negative (49% vs. 50%) and gram-positive (37% vs. 39%) bacteraemia as other patients. Cumulative 30-day mortality in patients with haematological malignancies was 32% vs. 20% in patients without any malignancy, yielding an adjusted MRR of 1.6 (95% CI 1.3-2.0). For patients with non-haematological malignancies the adjusted MRR was 1.5 (95% CI 1.4-1.7).
CONCLUSION: Despite a similar distribution of the microbial agents causing bacteraemia, patients with haematological malignancies and also patients with non-haematological malignancies had increased 30-day mortality of bacteraemia when compared with patients without any malignancy.

Entities:  

Mesh:

Year:  2005        PMID: 16352338     DOI: 10.1016/j.jinf.2005.10.024

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

1.  Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.

Authors:  J A Greenberg; M Z David; D L Pitrak; J B Hall; J P Kress
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

2.  Existing data sources for clinical epidemiology: The North Denmark Bacteremia Research Database.

Authors:  Henrik C Schønheyder; Mette Søgaard
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

3.  Bloodstream infections in patients with hematological malignancies: which is more fatal - cancer or resistant pathogens?

Authors:  Habip Gedik; Funda Simşek; Arzu Kantürk; Taner Yildirmak; Deniz Arica; Demet Aydin; Naciye Demirel; Osman Yokuş
Journal:  Ther Clin Risk Manag       Date:  2014-09-17       Impact factor: 2.423

4.  Clinical characteristics of peripheral venous catheter-associated gram-negative bloodstream infection among patients with malignancy.

Authors:  Toshiharu Sasaki; Sohei Harada; Shungo Yamamoto; Daisuke Ohkushi; Brian Hayama; Koichi Takeda; Kosuke Hoashi; Joji Shiotani; Kazumi Takehana; Yohei Doi
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

5.  Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy.

Authors:  Michael R Clausen; Matthew J Maurer; Sinna Pilgaard Ulrichsen; Thomas S Larsen; Bodil Himmelstrup; Dorthe Rønnov-Jessen; Brian K Link; Andrew L Feldman; Susan L Slager; Grzegorz S Nowakowski; Carrie A Thompson; Per Trøllund Pedersen; Jakob Madsen; Robert S Pedersen; Jette Sønderskov Gørløv; James R Cerhan; Mette Nørgaard; Francesco D'Amore
Journal:  Clin Epidemiol       Date:  2019-11-14       Impact factor: 4.790

6.  Multidrug resistant bacteremia in hematopoietic stem cell transplant recipients.

Authors:  Ameni Mellouli; Yosra Chebbi; Rym El Fatmi; Anis Raddaoui; Amel Lakhal; Lamia Torjmane; Nour Ben Abdeljelil; Dorra Belloumi; Salwa Ladeb; Tarek Ben Othmen; Wafa Achour
Journal:  Tunis Med       Date:  2021-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.